Validation of a Multivariate Serum Profile for Epithelial Ovarian Cancer Using a Prospective Multi-Site Collection

Laurie Stephen of Ampersand Biosciences co-authored an article in Nature Precedings titled, “Validation of a Multivariate Serum Profile for Epithelial Ovarian Cancer Using a Prospective Multi-Site Collection.” This article describes the use of retrospective collection of ovarian cancer and benign disease samples, in combination with a large set of multiplex immunoassays.